Added Value of Contrast-enhanced Ultrasonography for Percutaneous Radiofrequency Ablation

NACompletedINTERVENTIONAL
Enrollment

248

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

April 30, 2021

Study Completion Date

January 30, 2022

Conditions
Radiofrequency AblationUltrasonographyLiver Tumors
Interventions
PROCEDURE

Percutaneous Radiofrequency Ablation

In brief, ablation was performed using a 200-W multichannel generator and a switching monopolar technique with separate clustered electrodes. Tumor targeting was done under the guidance of CEUS-CT/MRI FI, and the ablation procedure was monitored with US-FI. The ablation procedure was terminated when the operator expected to complete the ablation of the index tumor with a minimum 5-mm ablative margin on the US-FI images.

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT05445973 - Added Value of Contrast-enhanced Ultrasonography for Percutaneous Radiofrequency Ablation | Biotech Hunter | Biotech Hunter